Table 4.

Average osteocalcin levels and MAP infection according to treatment groups among RA patients.

Treatment Group	Number of Patients Receiving Treatment	MAP Infection	Average Osteocalcin (ng/mL)
Anti-TNFα	20	6/20 (30.0%)	2.71 ± 0.82
Methotrexate	28	10/28 (35.7%)	2.49 ± 0.57
Corticosteroids	13	3/13 (23.1%)	2.98 ± 0.69
Hydroxychloroquine	9	4/9 (44.4%)	2.23 ± 0.26